Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-15-000794
Filing Date
2015-02-06
Accepted
2015-02-06 17:26:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5020615_actinium.htm 424B5 1174208
2 GRAPHIC image_001.jpg GRAPHIC 8308
  Complete submission text file 0001213900-15-000794.txt   1186854
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 15585728
SIC: 2834 Pharmaceutical Preparations